Navigation Links
Sorrento Therapeutics Awarded NIH Grant for MRSA Program
Date:5/21/2010

ey also cited the high quality of the investigational team and the impressive preliminary data supporting the program to date. In January, the Company obtained an exclusive license to The Scripps Research Institute's quorum quenching technology, which lays the scientific foundation for this program.

"We believe that the use of quorum sensing signal molecules as targets for the development of vaccines and antibody therapeutics using our proprietary technology platform is a novel and promising approach to combat a serious public health issue. We look forward to working with our colleagues at The Scripps Research Institute and Montana State University in developing novel antibody therapeutics and vaccines against MRSA," said Charlie Rodi, Ph.D., Vice President of Research and Development at Sorrento Therapeutics and the Principal Investigator on the grant.

For 2005, the Centers for Disease Control and Prevention estimated that 94,000 serious invasive MRSA infections occurred in the U.S. and more than 19,000 Americans died from these infections - more than from HIV/AIDS. A recent (2009) study from Duke University Medical Center looking at MRSA infections associated with surgery found a 35-fold increased risk of hospital readmission, a 7-fold increased risk of death, and more than $60,000 of additional charges per patient compared to uninfected controls. IMS Health reported that U.S. sales of antibiotics to treat MRSA exceeded $1 billion in 2007. Although a report from the Government Accounting Office indicates that no federal agency adequately monitors antibiotic resistance or evaluates its social and financial costs, various estimates place the annual cost to the healthcare system as high as

SOURCE Sorrento Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013   Direct to implant, or ... an appropriate option for many women with BRCA ... their breast cancer risk, or with breast cancer. ... and a second surgery to insert permanent implants, ... surgery as mastectomy can be a medically and ...
(Date:5/23/2013)... 23, 2013  BioElectronics Corporation (OTC Pink: BIEL), the ... on the FDA panel meeting for non-thermal shortwave diathermy: ... Pulsed Shortwave Therapy Meeting was held on May 21, ... The focus of the meeting was very narrow, in ... solely on the application of non-thermal shortwave diathermy for ...
(Date:5/23/2013)... 23, 2013  Datameer announced today that Cardinal ... discovery on their big data platform. Datameer gives ... need to quickly and easily visualize and understand ... Fortune 19 company, Cardinal Health is one of ... pharmaceuticals and medical products to more than 60,000 ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Cardinal Health Selects Datameer for Healthcare Data Discovery 2
... Calif., Feb. 3, 2011 SkinMedica, Inc., the ... States, today announced that it is introducing a ... innovation in redness in over two decades.  It ... proven to reduce visible redness.     ...
... 3, 2011 MedAssurant, Inc., a leading provider of ... joint study with the University of North Carolina (UNC) ... insulin to treat diabetes and the development of cancer. ... has been engaged to analyze data from its MORE2 ...
Cached Medicine Technology:SkinMedica Launches Redness Relief CalmPlex™ 2SkinMedica Launches Redness Relief CalmPlex™ 3UNC Selects MedAssurant to Support Investigation of Relationship Between Insulin and Cancer Development 2UNC Selects MedAssurant to Support Investigation of Relationship Between Insulin and Cancer Development 3
(Date:5/23/2013)... 23, 2013 Hile Design LLC is ... was awarded a Silver Creative Award at the Summit ... winning entry was for its “Open Doors” animation promoting ... Show” in the 2013 District 6 ADDY Awards for ... Summit Creative Award recognizes and celebrates the creative achievements ...
(Date:5/23/2013)... 2013 Fresh Healthy Vending is a ... with healthy food and drinks in locations such as ... full-service marketing and advertising department has a goal of ... for their franchisees, and to promote the Fresh Healthy ... in many leading publications and TV networks across the ...
(Date:5/23/2013)... May 23, 2013 Jim Fitzpatrick just ... Fitzpatrick Advertising developed yet another outside-of-the-box approach to reaching ... News.com, he brings daily newscasts to the retail automotive ... delivery of a broadcast news format. , CBTNews.com ... automotive news. Co-anchors Bridget Everett and Russell Brown host ...
(Date:5/23/2013)... Springs, FL (PRWEB) May 23, 2013 The ... about redefining retirement. Many Americans are facing a dim life ... the Late Boomers -- those born after 1955 -- carry ... card debt. But all hope for The Golden Years is ... how to reduce debt and keep earning after reaching the ...
(Date:5/23/2013)... that can cause rapidly progressing, life threatening meningitis and ... we have not known how it attaches to the ... it attaches to the airway to colonise", People can ... symptoms, while some people progress to invasive disease. ... of how the bacterium colonises the airway. Now that ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2
... VaniqaT is a prescription drug which was approved by the ... treating excessive facial hair ,in women, which is often part ... alternative for women for whom this problem is considered ... once a ,week for hair removal. Vaniqa is actually ...
... can be regenerated using stem cells from blood -- ... grow their own liver transplants using bone marrow. This adds ... as "master cells" because they can produce a variety of ... create custom-grown organ transplants. , , ,"The liver is an ...
... in Dallas soon report that amphetamines may speed up the ... , ,This study was done on patients who had suffered from ... oxygen to the brain., , ,Amphetamines were given to 30 stroke ... while they don't know for sure until the results are finalized, ...
... symptoms of depression are at an increased risk of stroke, ... Prevention. In particular, depressed African Americans showed the largest ... levels of depression had a 73% increase in their risk ... actually caused the stroke, or if some unknown factor related ...
... the AIDS crisis ravaging sub-Saharan Africa dominates much of the ... and AIDS workers are sounding the alarm for what many ... very serious catastrophe in the offing, and if there's an ... it's not any of the other superpowers--the big threat to ...
... from June issue of the American Journal of Epidemiology ... rates than taller people from most causes except cancer. ... women undertaken by Dr.Pekka Jousilahti and his colleagues from ... was found that there was an association between adult ...
Cached Medicine News:
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
... The integration of Trabecular Metal ... implant design results in a fusion ... only meets surgeon demands for initial ... a wide variety of shell and ...
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: